Disulfidptosis-Associated lncRNAs are Potential Biomarkers for Predicting Immune Response and Prognosis Within Individuals Diagnosed with Hepatocellular Carcinoma.
Qian WeiYu-Chao HouFei-Fei MaoJin-Kai FengXu WangShu-Qun ChengPublished in: Hepatic medicine : evidence and research (2023)
In summary, our research introduces a novel predictive tool utilizing disulfidptosis-related lncRNAs, offering potential guidance for the therapeutic management of HCC.